These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

194 related articles for article (PubMed ID: 3469783)

  • 1. ['New look' biotechnology].
    de Voogd van der Straaten WA
    Tijdschr Diergeneeskd; 1987 Jan; 112(1):3-8. PubMed ID: 3469783
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Biotechnology: a selective survey.
    Goldsby RA
    Avian Dis; 1986; 30(1):3-11. PubMed ID: 3460566
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Use of phage libraries for the in vitro production of recombinant monoclonal antibodies of predetermined specificity].
    Flego M; Ascione A; Pini A; Mennella V; Dupuis ML; Benagiano G; Cianfriglia M
    Ann Ist Super Sanita; 2002; 38(4):401-10. PubMed ID: 12760337
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The rapid discovery of engineered antibodies.
    Wang M; He M
    IDrugs; 2007 Aug; 10(8):562-5. PubMed ID: 17665332
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Biochemical engineering.
    Carrondo MJ; Aunins JG
    Curr Opin Biotechnol; 2004 Oct; 15(5):441-3. PubMed ID: 15464375
    [No Abstract]   [Full Text] [Related]  

  • 6. [Animal husbandry and biotechnology].
    Drost M
    Tijdschr Diergeneeskd; 1987 Jan; 112(1):9-15. PubMed ID: 3469784
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Recent progress in biomolecular engineering.
    Ryu DD; Nam DH
    Biotechnol Prog; 2000; 16(1):2-16. PubMed ID: 10662483
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Industrial processes with animal cells.
    Kretzmer G
    Appl Microbiol Biotechnol; 2002 Jul; 59(2-3):135-42. PubMed ID: 12111138
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Yeast systems biotechnology for the production of heterologous proteins.
    Graf A; Dragosits M; Gasser B; Mattanovich D
    FEMS Yeast Res; 2009 May; 9(3):335-48. PubMed ID: 19341379
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Production and analysis of proteins by recombinant DNA technology.
    Pestka S
    Bioprocess Technol; 1990; 7():235-65. PubMed ID: 1366823
    [No Abstract]   [Full Text] [Related]  

  • 11. Monoclonal antibodies: methods and clinical laboratory applications.
    Nakamura RM
    Clin Physiol Biochem; 1983; 1(2-5):160-72. PubMed ID: 6396016
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Global physiological understanding and metabolic engineering of microorganisms based on omics studies.
    Park SJ; Lee SY; Cho J; Kim TY; Lee JW; Park JH; Han MJ
    Appl Microbiol Biotechnol; 2005 Sep; 68(5):567-79. PubMed ID: 16041571
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Renewal of EBV-hybridoma method: efficient generation of recombinant fully human neutralizing IgG antibodies specific for tetanus toxin by use of tetroma cells.
    Ainai A; Kawase T; Ida A; Maeda Y; Ohba H; Ikeda Y; Sato H; Takahashi M; Chiba J
    Hum Antibodies; 2006; 15(4):139-54. PubMed ID: 17522436
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Monoclonal antibodies: technology and potential use.
    Antczak DF
    J Am Vet Med Assoc; 1982 Nov; 181(10):1005-10. PubMed ID: 6757209
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Biotechnology: an introduction to recombinant DNA technology and product availability.
    Evens RP; Witcher M
    Ther Drug Monit; 1993 Dec; 15(6):514-20. PubMed ID: 8122286
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Biotech pharmaceuticals and biotherapy: an overview.
    Steinberg FM; Raso J
    J Pharm Pharm Sci; 1998; 1(2):48-59. PubMed ID: 10945918
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The prospective of the biotechnology industry on changing technology in pathology.
    Schoepke HG
    Arch Pathol Lab Med; 1987 Jul; 111(7):596-600. PubMed ID: 3475045
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Development of a fusion partner cell line for efficient production of human monoclonal antibodies from peripheral blood lymphocytes.
    Kalantarov GF; Rudchenko SA; Lobel L; Trakht I
    Hum Antibodies; 2002; 11(3):85-96. PubMed ID: 12454369
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Farmers in biotechnology].
    Sanders JP
    Tijdschr Diergeneeskd; 1987 Jan; 112(1):20-6. PubMed ID: 3469782
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Science of evaluating the characteristics, quality and safety of biotechnological products: RDNA-derived products, cell culture technology-derived products, gene therapy products, cellular therapy products, and transgenic animal-derived protein products and cellular products].
    Hayakawa T
    Kokuritsu Iyakuhin Shokuhin Eisei Kenkyusho Hokoku; 1999; (117):1-38. PubMed ID: 10859934
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.